Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

A Novel Oxidovanadium (IV)-Orotate Complex as an Alternative Antidiabetic Agent: Synthesis, Characterization, and Biological Assessments.

Naglah AM, Al-Omar MA, Almehizia AA, Bhat MA, Afifi WM, Al-Wasidi AS, Al-Humaidi JY, Refat MS.

Biomed Res Int. 2018 Dec 23;2018:8108713. doi: 10.1155/2018/8108713. eCollection 2018.

2.

Synthesis, characterization and antidiabetic effects of vanadyl(II) adenosine monophosphate amino acid mixed-ligand complexes.

Naglah AM, Al-Omar MA, Kalmouch A, Alsuhaibani AM, El-Didamony AM, Hassan N, Taleb SA, Refat MS, Almehizia AA, Bhat MA, Al-Shakliah NS, Al-Humaidi JY, Al-Wasidi AS.

Future Med Chem. 2019 Jan 15. doi: 10.4155/fmc-2018-0471. [Epub ahead of print]

PMID:
30642200
3.

A One-Pot Biginelli Synthesis and Characterization of Novel Dihydropyrimidinone Derivatives Containing Piperazine/Morpholine Moiety.

Bhat MA, Al-Omar MA, Ghabbour HA, Naglah AM.

Molecules. 2018 Jun 27;23(7). pii: E1559. doi: 10.3390/molecules23071559.

4.

Indole Derivatives as Cyclooxygenase Inhibitors: Synthesis, Biological Evaluation and Docking Studies.

Bhat MA, Al-Omar MA, Raish M, Ansari MA, Abuelizz HA, Bakheit AH, Naglah AM.

Molecules. 2018 May 24;23(6). pii: E1250. doi: 10.3390/molecules23061250.

5.

Synthesis and in vivo anti-ulcer evaluation of some novel piperidine linked dihydropyrimidinone derivatives.

Ahmad Bhat M, Al-Omar MA, Naglah AM.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):978-988. doi: 10.1080/14756366.2018.1474212.

6.

Synthesis of a new insulin-mimetic anti-diabetic drug containing vitamin A and vanadium(IV) salt: Chemico-biological characterizations.

Adam AMA, Naglah AM, Al-Omar MA, Refat MS.

Int J Immunopathol Pharmacol. 2017 Sep;30(3):272-281. doi: 10.1177/0394632017719601. Epub 2017 Jul 21.

7.

Charge transfer interaction of organic p-acceptors with the anti-hyperuricemic drug allopurinol: Insights from IR, Raman, 1H NMR and 13C NMR spectroscopies.

Refat MS, Saad HA, Adam AM, Al-Omar MA, Naglah AM.

Acta Pharm. 2016 Dec 1;66(4):533-542. doi: 10.1515/acph-2016-0045.

PMID:
27749247
8.

Spectroscopic, structural characterizations and antioxidant capacity of the chromium (III) niacinamide compound as a diabetes mellitus drug model.

Refat MS, El-Megharbel SM, Hussien MA, Hamza RZ, Al-Omar MA, Naglah AM, Afifi WM, Kobeasy MI.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Feb 15;173:122-131. doi: 10.1016/j.saa.2016.08.053. Epub 2016 Aug 30.

PMID:
27619974
9.

New Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Inhibitors, Nalidixic Acid Linked to Isatin Schiff Bases via Certain l-Amino Acid Bridges.

Naglah AM, Ahmed AF, Wen ZH, Al-Omar MA, Amr Ael-G, Kalmouch A.

Molecules. 2016 Apr 15;21(4):498. doi: 10.3390/molecules21040498.

10.

Supplemental Content

Loading ...
Support Center